SENSITIVITY OF GRAFT REJECTION IN RATS TO LOCAL IMMUNOSUPPRESSIVE THERAPY
- 1 December 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 46 (6) , 820-824
- https://doi.org/10.1097/00007890-198812000-00006
Abstract
In this study we investigated whether allograft rejection is sensitive to local immunosuppressive therapy. In rats, cardiac transplantations (BN .fwdarw. Lewis) were performed with venous return on the portal vein of the recipient. For local treatment the topical steroid budesonide was infused with an osmotic minipump directly into the carotid artery of the transplant. Budesonide is rapidly cleared by the liver, and cardiac tissue binding of the drug is high. Hence, local budesonide administration, 120 .mu.g/kg/day, resulted in high drug levels within the graft (29.6 ng/mg) and low systemic drug levels (0.34 ng/ml). Systemic drug levels were so low that systemic biological effects of the drug during local administration were not measurable. In contrast systemic drug delivery, via the jugular vein of recipient, resulted in similar drug levels within the graft (31.0 ng/mg), but with high systemic drug levels within the graft (31.0 ng/mg), but with high systemic drug levels (1.65 ng/ml) and important systemic side effects. Both local and systemic administration of budesonide, 120 .mu.g/kg/day for 13 days, resulted in significant prolongation of graft survival; median graft survival time was respectively 19.5 days and 20.0 days, compared with 7 days in controls. These results demonstrate that allograft rejection can be treated locally without significant systemic immunosuppression.This publication has 23 references indexed in Scilit:
- Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity.The Journal of Experimental Medicine, 1982
- Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in manEuropean Journal of Clinical Pharmacology, 1982
- Influence of 16α,17α-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoidsThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.The Journal of Immunology, 1981
- N-ACYL-GAMMA-GLUTAMYL DERIVATIVES OF SULFAMETHOXAZOLE AS MODELS OF KIDNEY-SELECTIVE PRODRUGS1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- In Situ Effector Mechanisms in Rat Kidney Allograft Rejection: III. Kinetics of the Inflammatory Response and Generation of Donor‐directed Killer CellsScandinavian Journal of Immunology, 1979
- Pharmacokinetic studies of a potent glucocorticoid (budesonide) in dogs by high-performance liquid chromatographyThe Journal of Steroid Biochemistry and Molecular Biology, 1979
- GLUCOCORTICOID-INDUCED INHIBITION OF T-CELL GROWTH-FACTOR PRODUCTION .1. EFFECT ON MITOGEN-INDUCED LYMPHOCYTE-PROLIFERATION1979
- Role of major histocompatibility complex gene products in delayed-type hypersensitivity.Proceedings of the National Academy of Sciences, 1976